IDYA
Price
$17.42
Change
-$0.76 (-4.18%)
Updated
May 9 closing price
Capitalization
1.53B
93 days until earnings call
LRMR
Price
$2.12
Change
-$0.12 (-5.36%)
Updated
May 9 closing price
Capitalization
135.74M
88 days until earnings call
Ad is loading...

IDYA vs LRMR

Header iconIDYA vs LRMR Comparison
Open Charts IDYA vs LRMRBanner chart's image
IDEAYA Biosciences
Price$17.42
Change-$0.76 (-4.18%)
Volume$1.19M
Capitalization1.53B
Larimar Therapeutics
Price$2.12
Change-$0.12 (-5.36%)
Volume$786.83K
Capitalization135.74M
IDYA vs LRMR Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. LRMR commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and LRMR is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (IDYA: $17.42 vs. LRMR: $2.12)
Brand notoriety: IDYA and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 85% vs. LRMR: 69%
Market capitalization -- IDYA: $1.53B vs. LRMR: $135.74M
IDYA [@Biotechnology] is valued at $1.53B. LRMR’s [@Biotechnology] market capitalization is $135.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, IDYA is a better buy in the long-term than LRMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while LRMR’s TA Score has 4 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 6 bearish.
  • LRMR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both IDYA and LRMR are a bad buy in the short-term.

Price Growth

IDYA (@Biotechnology) experienced а -16.77% price change this week, while LRMR (@Biotechnology) price change was -28.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

LRMR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.53B) has a higher market cap than LRMR($136M). IDYA YTD gains are higher at: -32.218 vs. LRMR (-45.220). LRMR has higher annual earnings (EBITDA): -73.44M vs. IDYA (-323.14M). IDYA has more cash in the bank: 676M vs. LRMR (204M). LRMR has less debt than IDYA: LRMR (5.36M) vs IDYA (19.2M). IDYA has higher revenues than LRMR: IDYA (7M) vs LRMR (0).
IDYALRMRIDYA / LRMR
Capitalization1.53B136M1,122%
EBITDA-323.14M-73.44M440%
Gain YTD-32.218-45.22071%
P/E RatioN/AN/A-
Revenue7M0-
Total Cash676M204M331%
Total Debt19.2M5.36M358%
FUNDAMENTALS RATINGS
IDYA vs LRMR: Fundamental Ratings
IDYA
LRMR
OUTLOOK RATING
1..100
1929
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
21
Undervalued
PROFIT vs RISK RATING
1..100
66100
SMR RATING
1..100
48100
PRICE GROWTH RATING
1..100
6264
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (21) in the null industry is somewhat better than the same rating for IDYA (62). This means that LRMR’s stock grew somewhat faster than IDYA’s over the last 12 months.

IDYA's Profit vs Risk Rating (66) in the null industry is somewhat better than the same rating for LRMR (100). This means that IDYA’s stock grew somewhat faster than LRMR’s over the last 12 months.

IDYA's SMR Rating (48) in the null industry is somewhat better than the same rating for LRMR (100). This means that IDYA’s stock grew somewhat faster than LRMR’s over the last 12 months.

IDYA's Price Growth Rating (62) in the null industry is in the same range as LRMR (64). This means that IDYA’s stock grew similarly to LRMR’s over the last 12 months.

IDYA's P/E Growth Rating (100) in the null industry is in the same range as LRMR (100). This means that IDYA’s stock grew similarly to LRMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDYALRMR
RSI
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAAHX16.730.35
+2.14%
GMO Resources R6
BROIX21.270.15
+0.71%
BlackRock Advantage International Instl
GABEX5.880.01
+0.17%
Gabelli Equity Income AAA
HFLGX10.91-0.01
-0.09%
Hennessy Cornerstone Large Growth Inv
MSVDX5.20-0.08
-1.52%
Morgan Stanley Vitality Portfolio I

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with RCKT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-4.18%
RCKT - IDYA
58%
Loosely correlated
-0.71%
IMNM - IDYA
57%
Loosely correlated
-3.24%
NTLA - IDYA
55%
Loosely correlated
-1.93%
KRYS - IDYA
55%
Loosely correlated
-3.64%
XENE - IDYA
54%
Loosely correlated
-1.46%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with ERAS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
-5.36%
ERAS - LRMR
49%
Loosely correlated
N/A
SVRA - LRMR
49%
Loosely correlated
-11.18%
IMNM - LRMR
49%
Loosely correlated
-3.24%
IDYA - LRMR
47%
Loosely correlated
-4.18%
PRME - LRMR
46%
Loosely correlated
-1.52%
More